Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Leukemia, Myeloid, Chronic-Phase 9 Breast Neoplasms 6 Leukemia 5 Philadelphia Chromosome 4 Blast Crisis 4 Neoplasms 3 Bronchiolitis Obliterans Syndrome 3 Neoplasm Metastasis 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Myeloid 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Translocation, Genetic 1 Thymus Neoplasms 1 Thymoma 1 Pathologic Processes 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms by Histologic Type 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Mesothelioma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Hematologic Diseases 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Bone Marrow Diseases 1 Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

Dexamethasone 808 Bortezomib 446 Lenalidomide 430 Cyclophosphamide 336 Melphalan 250 Calcium Dobesilate 236 daratumumab 217 pomalidomide 201 carfilzomib 181 fludarabine phosphate 131 Thalidomide 121 fludarabine 118 Peripheral Blood Stem Cell Transplantation 117 Filgrastim 111 ixazomib 85 Mycophenolic Acid 85 Granulocyte Colony-Stimulating Factor 84 Busulfan 83 Whole-Body Irradiation 80 Tacrolimus 75 dexamethasone acetate 74 Cyclosporine 67 Prednisone 64 dexamethasone 21-phosphate 63 isatuximab 62 elotuzumab 60 auricularum 57 Antilymphocyte Serum 55 belantamab mafodotin 54 Etoposide 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × bosutinib × Clear all

NCT03297606 2026-03-27

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡